Research Solutions, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Research Solutions, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Jun 30, 2019 | $28.79M | Sep 19, 2019 |
| FY2019 | Jun 30, 2018 | $28.02M | Sep 19, 2019 |
| FY2018 | Jun 30, 2017 | $25.75M | Sep 20, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $49.06M | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | $44.62M | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | $37.70M | Sep 20, 2024 |
| FY2023 | Jun 30, 2022 | $32.93M | Sep 15, 2023 |
| FY2022 | Jun 30, 2021 | $31.76M | Sep 23, 2022 |
| FY2021 | Jun 30, 2020 | $31.06M | Sep 23, 2021 |
| FY2020 | Jun 30, 2019 | $28.79M | Sep 24, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Jun 30, 2016 | $34.36M | Sep 20, 2016 |
| FY2016 | Jun 30, 2015 | $31.90M | Sep 20, 2016 |
| FY2015 | Jun 30, 2014 | $28.48M | Sep 8, 2015 |
| FY2014 | Jun 30, 2013 | $45.50M | Sep 29, 2014 |
| FY2013 | Jun 30, 2012 | $42.82M | Sep 30, 2013 |
| FY2012 | Jun 30, 2011 | $33.50M | Oct 9, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $24.20M | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | $19.64M | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | $14.70M | Sep 20, 2024 |
| FY2023 | Jun 30, 2022 | $12.02M | Sep 15, 2023 |
| FY2022 | Jun 30, 2021 | $10.29M | Sep 23, 2022 |
| FY2021 | Jun 30, 2020 | $9.64M | Sep 23, 2021 |
| FY2020 | Jun 30, 2019 | $8.34M | Sep 24, 2020 |
| FY2019 | Jun 30, 2018 | $7.35M | Sep 19, 2019 |
| FY2018 | Jun 30, 2017 | $6.10M | Sep 20, 2018 |
| FY2017 | Jun 30, 2016 | $5.63M | Sep 18, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.27M | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | ($3.79M) | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | $571.6K | Sep 20, 2024 |
| FY2023 | Jun 30, 2022 | ($1.63M) | Sep 15, 2023 |
| FY2022 | Jun 30, 2021 | ($285.1K) | Sep 23, 2022 |
| FY2021 | Jun 30, 2020 | ($662.2K) | Sep 23, 2021 |
| FY2020 | Jun 30, 2019 | ($960.0K) | Sep 24, 2020 |
| FY2019 | Jun 30, 2018 | ($1.68M) | Sep 19, 2019 |
| FY2018 | Jun 30, 2017 | ($2.29M) | Sep 20, 2018 |
| FY2017 | Jun 30, 2016 | ($497.9K) | Sep 18, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $2.50M | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | ($769.5K) | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | $238.6K | Sep 20, 2024 |
| FY2023 | Jun 30, 2022 | ($1.63M) | Sep 15, 2023 |
| FY2022 | Jun 30, 2021 | ($283.0K) | Sep 23, 2022 |
| FY2021 | Jun 30, 2020 | ($851.9K) | Sep 23, 2021 |
| FY2020 | Jun 30, 2019 | ($1.25M) | Sep 24, 2020 |
| FY2019 | Jun 30, 2018 | ($1.95M) | Sep 19, 2019 |
| FY2018 | Jun 30, 2017 | ($3.08M) | Sep 20, 2018 |
| FY2017 | Jun 30, 2016 | ($1.29M) | Sep 18, 2017 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $2.53M | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | $2.43M | Sep 19, 2025 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $20.45M | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | $19.57M | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | $14.41M | Sep 20, 2024 |
| FY2023 | Jun 30, 2022 | $13.63M | Sep 15, 2023 |
| FY2022 | Jun 30, 2021 | $10.56M | Sep 23, 2022 |
| FY2021 | Jun 30, 2020 | $10.47M | Sep 23, 2021 |
| FY2020 | Jun 30, 2019 | $9.56M | Sep 24, 2020 |
| FY2019 | Jun 30, 2018 | $9.15M | Sep 19, 2019 |
| FY2018 | Jun 30, 2017 | $9.06M | Sep 20, 2018 |
| FY2017 | Jun 30, 2016 | $6.83M | Sep 18, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $7.02M | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | $3.55M | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | $3.38M | Sep 20, 2024 |
| FY2023 | Jun 30, 2022 | ($417.2K) | Sep 15, 2023 |
| FY2022 | Jun 30, 2021 | $1.87M | Sep 23, 2022 |
| FY2021 | Jun 30, 2020 | $2.42M | Sep 23, 2021 |
| FY2020 | Jun 30, 2019 | $576.4K | Sep 24, 2020 |
| FY2019 | Jun 30, 2018 | ($605.3K) | Sep 19, 2019 |
| FY2018 | Jun 30, 2017 | ($436.8K) | Sep 20, 2018 |
| FY2016 | Jun 30, 2016 | $185.2K | Sep 20, 2016 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $19.3K | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | $71.5K | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | $47.2K | Sep 20, 2024 |
| FY2023 | Jun 30, 2022 | $44.3K | Sep 15, 2023 |
| FY2022 | Jun 30, 2021 | $19.9K | Sep 23, 2022 |
| FY2021 | Jun 30, 2020 | $0 | Sep 23, 2021 |
| FY2020 | Jun 30, 2019 | $15.8K | Sep 24, 2020 |
| FY2019 | Jun 30, 2018 | $29.3K | Sep 19, 2019 |
| FY2018 | Jun 30, 2017 | $59.6K | Sep 20, 2018 |
| FY2017 | Jun 30, 2016 | $58.4K | Sep 18, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $46.12M | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | $41.86M | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | $21.83M | Sep 20, 2024 |
| FY2023 | Jun 30, 2022 | $17.03M | Sep 15, 2023 |
| FY2022 | Jun 30, 2021 | $16.92M | Sep 23, 2022 |
| FY2021 | Jun 30, 2020 | $14.81M | Sep 23, 2021 |
| FY2020 | Jun 30, 2019 | $10.41M | Sep 24, 2020 |
| FY2019 | Jun 30, 2018 | $9.96M | Sep 19, 2019 |
| FY2018 | Jun 30, 2017 | $12.56M | Sep 20, 2018 |
| FY2017 | Jun 30, 2016 | $12.37M | Sep 18, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $32.19M | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | $30.17M | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | $14.50M | Sep 20, 2024 |
| FY2020 | Jun 30, 2020 | $9.95M | Sep 24, 2020 |
| FY2020 | Jun 30, 2019 | $7.38M | Sep 24, 2020 |
| FY2019 | Jun 30, 2018 | $6.68M | Sep 19, 2019 |
| FY2018 | Jun 30, 2017 | $8.22M | Sep 20, 2018 |
| FY2017 | Jun 30, 2016 | $6.33M | Sep 18, 2017 |
| FY2015 | Jun 30, 2015 | $5.69M | Sep 8, 2015 |
| FY2015 | Jun 30, 2014 | $9.46M | Sep 8, 2015 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $13.93M | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | $11.69M | Sep 19, 2025 |
| FY2025 | Jun 30, 2023 | $7.33M | Sep 19, 2025 |
| FY2024 | Jun 30, 2022 | $4.88M | Sep 20, 2024 |
| FY2023 | Jun 30, 2021 | $5.43M | Sep 15, 2023 |
| FY2022 | Jun 30, 2020 | $4.86M | Sep 23, 2022 |
| FY2021 | Jun 30, 2019 | $3.03M | Sep 23, 2021 |
| FY2020 | Jun 30, 2018 | $3.28M | Sep 24, 2020 |
| FY2019 | Jun 30, 2017 | $4.34M | Sep 19, 2019 |
| FY2018 | Jun 30, 2016 | $6.04M | Sep 20, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $16.37M | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | $16.32M | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | $0 | Sep 20, 2024 |
| FY2012 | Jun 30, 2012 | $0 | Oct 9, 2012 |
| FY2012 | Jun 30, 2011 | $1.57M | Oct 9, 2012 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($25.04M) | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | ($26.31M) | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | ($22.52M) | Sep 20, 2024 |
| FY2023 | Jun 30, 2022 | ($23.09M) | Sep 15, 2023 |
| FY2022 | Jun 30, 2021 | ($21.46M) | Sep 23, 2022 |
| FY2021 | Jun 30, 2020 | ($21.18M) | Sep 23, 2021 |
| FY2020 | Jun 30, 2019 | ($20.51M) | Sep 24, 2020 |
| FY2019 | Jun 30, 2018 | ($19.55M) | Sep 19, 2019 |
| FY2018 | Jun 30, 2017 | ($17.88M) | Sep 20, 2018 |
| FY2017 | Jun 30, 2016 | ($15.58M) | Sep 18, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $12.23M | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | $6.10M | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | $13.55M | Sep 20, 2024 |
| FY2023 | Jun 30, 2022 | $10.60M | Sep 15, 2023 |
| FY2022 | Jun 30, 2021 | $11.00M | Sep 23, 2022 |
| FY2021 | Jun 30, 2020 | $9.31M | Sep 23, 2021 |
| FY2020 | Jun 30, 2019 | $5.35M | Sep 24, 2020 |
| FY2019 | Jun 30, 2018 | $4.91M | Sep 19, 2019 |
| FY2019 | Jun 30, 2017 | $5.77M | Sep 19, 2019 |
| FY2018 | Jun 30, 2016 | $6.08M | Sep 20, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Sep 20, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Sep 15, 2023 |
| FY2016 | Jun 30, 2016 | 0 | Sep 20, 2016 |
| FY2016 | Jun 30, 2015 | 0 | Sep 20, 2016 |
| FY2015 | Jun 30, 2014 | 0 | Sep 8, 2015 |
| FY2014 | Jun 30, 2013 | 0 | Sep 29, 2014 |
| FY2013 | Jun 30, 2012 | 0 | Sep 30, 2013 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Sep 20, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Sep 15, 2023 |
| FY2016 | Jun 30, 2016 | 0 | Sep 20, 2016 |
| FY2016 | Jun 30, 2015 | 0 | Sep 20, 2016 |
| FY2015 | Jun 30, 2014 | 0 | Sep 8, 2015 |
| FY2014 | Jun 30, 2013 | 0 | Sep 29, 2014 |
| FY2013 | Jun 30, 2012 | 0 | Sep 30, 2013 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 32.48M | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | 32.30M | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | 29.49M | Sep 20, 2024 |
| FY2023 | Jun 30, 2022 | 27.08M | Sep 15, 2023 |
| FY2022 | Jun 30, 2021 | 26.50M | Sep 23, 2022 |
| FY2021 | Jun 30, 2020 | 26.03M | Sep 23, 2021 |
| FY2020 | Jun 30, 2019 | 24.38M | Sep 24, 2020 |
| FY2019 | Jun 30, 2018 | 24.02M | Sep 19, 2019 |
| FY2018 | Jun 30, 2017 | 23.88M | Sep 20, 2018 |
| FY2017 | Jun 30, 2016 | 23.81M | Sep 18, 2017 |